Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
137 | 3 | HUMAN PAPILLOMAVIRUS//HPV//HEAD AND NECK CANCER | 66822 |
1609 | 2 | ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY//AGNOR//NUCLEOLAR ORGANIZER REGIONS | 7326 |
37594 | 1 | MORPHONUCLEAR MODIFICATIONS//DIGITAL CELL IMAGE ANALYSIS//INTERCALATING DRUGS | 80 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | MORPHONUCLEAR MODIFICATIONS | authKW | 1969820 | 6% | 100% | 5 |
2 | DIGITAL CELL IMAGE ANALYSIS | authKW | 1608680 | 9% | 58% | 7 |
3 | INTERCALATING DRUGS | authKW | 525284 | 3% | 67% | 2 |
4 | A TETRAZOLE ASSAY | authKW | 393964 | 1% | 100% | 1 |
5 | ANTICANCER ALKYLATING DRUGS | authKW | 393964 | 1% | 100% | 1 |
6 | CELL CLONE ARCHITECTURE | authKW | 393964 | 1% | 100% | 1 |
7 | CELL LINE U 87 | authKW | 393964 | 1% | 100% | 1 |
8 | CRC MED ONCOLCANC CAMPAIGN BEATSON S | address | 393964 | 1% | 100% | 1 |
9 | HUMAN NSCLCS | authKW | 393964 | 1% | 100% | 1 |
10 | INVIVO PROLIFERATION | authKW | 393964 | 1% | 100% | 1 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 1285 | 65% | 0% | 52 |
2 | CYTOLOGY & HISTOLOGY | 206 | 3% | 0% | 2 |
3 | Radiology, Nuclear Medicine & Medical Imaging | 31 | 9% | 0% | 7 |
4 | Pharmacology & Pharmacy | 24 | 13% | 0% | 10 |
5 | Anatomy & Morphology | 23 | 3% | 0% | 2 |
6 | Endocrinology & Metabolism | 8 | 5% | 0% | 4 |
7 | Biology | 3 | 3% | 0% | 2 |
8 | Multidisciplinary Sciences | 3 | 1% | 0% | 1 |
9 | Toxicology | 3 | 3% | 0% | 2 |
10 | Reproductive Biology | 2 | 1% | 0% | 1 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CRC MED ONCOLCANC CAMPAIGN BEATSON S | 393964 | 1% | 100% | 1 |
2 | ONCOL EORTC NEW DRUG DEV OFF | 393964 | 1% | 100% | 1 |
3 | ALEXANDER STONE BLDG | 196981 | 1% | 50% | 1 |
4 | NUTR DIETET | 77 | 1% | 0% | 1 |
5 | TOXICOL | 16 | 1% | 0% | 1 |
6 | PHARM | 8 | 4% | 0% | 3 |
7 | PHARMACOL | 1 | 1% | 0% | 1 |
8 | HLTH SCI | 0 | 1% | 0% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | LAHEY CLINIC FOUNDATION BULLETIN | 78791 | 1% | 20% | 1 |
2 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 5229 | 6% | 0% | 5 |
3 | ANTICANCER RESEARCH | 3978 | 18% | 0% | 14 |
4 | CANCER RESEARCH THERAPY & CONTROL | 3029 | 1% | 1% | 1 |
5 | ONCOLOGY | 1575 | 5% | 0% | 4 |
6 | ARCHIVES OF BIOLOGY | 1441 | 1% | 0% | 1 |
7 | JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS | 1330 | 3% | 0% | 2 |
8 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1270 | 5% | 0% | 4 |
9 | IRCS MEDICAL SCIENCE-BIOCHEMISTRY | 1082 | 4% | 0% | 3 |
10 | PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION | 690 | 1% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |